Total Payments
$419,217
2024 Payments
$114,714
Companies
34
Transactions
655
Medicare Patients
3,972
Medicare Billing
$774,739
Payment Breakdown by Category
Other$226,614 (54.1%)
Consulting$72,384 (17.3%)
Research$57,853 (13.8%)
Travel$41,422 (9.9%)
Food & Beverage$20,918 (5.0%)
Education$26.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $226,614 | 75 | 54.1% |
| Consulting Fee | $72,384 | 25 | 17.3% |
| Unspecified | $57,853 | 13 | 13.8% |
| Travel and Lodging | $41,422 | 100 | 9.9% |
| Food and Beverage | $20,918 | 441 | 5.0% |
| Education | $26.00 | 1 | 0.0% |
Payments by Type
General
$361,364
642 transactions
Research
$57,853
13 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $140,119 | 172 | $0 (2024) |
| GENZYME CORPORATION | $86,501 | 71 | $0 (2024) |
| Optinose US, Inc. | $73,131 | 150 | $0 (2024) |
| Neurent Medical Limited | $56,412 | 3 | $0 (2024) |
| Medical Device Business Services, Inc. | $16,888 | 11 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $14,012 | 11 | $0 (2021) |
| Merck Sharp & Dohme LLC | $7,441 | 13 | $0 (2023) |
| Genentech USA, Inc. | $6,444 | 7 | $0 (2024) |
| Stryker Corporation | $6,039 | 57 | $0 (2024) |
| Intersect ENT, Inc. | $4,655 | 48 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114,714 | 74 | Neurent Medical Limited ($56,412) |
| 2023 | $78,755 | 108 | Regeneron Healthcare Solutions, Inc. ($51,809) |
| 2022 | $54,063 | 95 | Regeneron Healthcare Solutions, Inc. ($40,827) |
| 2021 | $64,422 | 105 | Regeneron Healthcare Solutions, Inc. ($29,973) |
| 2020 | $27,219 | 77 | OptiNose US, Inc. ($9,040) |
| 2019 | $39,625 | 86 | OptiNose US, Inc. ($19,817) |
| 2018 | $20,103 | 59 | Optinose US, Inc. ($9,900) |
| 2017 | $20,315 | 51 | Medical Device Business Services, Inc. ($16,888) |
All Payment Transactions
655 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | — | Cash or cash equivalent | $12,538.60 | Research |
| Study: NEUROMARK Randomized Controlled Trial • Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 11/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $163.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | — | Cash or cash equivalent | $3,028.00 | Research |
| Study: NEUROMARK Registry Study • Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $59.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $86.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $132.64 | General |
| Category: EAR NOSE & THROAT | ||||||
| 09/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $123.13 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,973.00 | General |
| Category: Immunology | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | In-kind items and services | $290.80 | General |
| Category: Immunology | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | Cash or cash equivalent | $168.84 | General |
| Category: Immunology | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $81.60 | General |
| Category: Immunology | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | Cash or cash equivalent | $5.22 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Spirair, Inc. | SeptAlign (Device), SeptAlign | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Otolarynology | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $594.07 | General |
| 08/12/2024 | Medtronic, Inc. | NUVENT (Device) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Sinus Surgery | ||||||
| 08/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NEUROMARK Registry Study | Neurent Medical Limited | $43,873 | 2 |
| NEUROMARK Randomized Controlled Trial | Neurent Medical Limited | $12,539 | 1 |
| A RANDOMISED PHIII STUDY TO ASSESS THE EFFECT OF 100 MG SC MEPOLIZUMAB | GlaxoSmithKline, LLC. | $1,441 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,031 | 4,455 | $574,721 | $206,975 |
| 2022 | 21 | 1,141 | 3,991 | $530,493 | $201,865 |
| 2021 | 17 | 899 | 2,882 | $433,416 | $186,605 |
| 2020 | 18 | 901 | 3,717 | $443,616 | $179,295 |
Total Patients
3,972
Total Services
15,045
Medicare Billing
$774,739
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 256 | 583 | $204,050 | $78,273 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 241 | 585 | $142,155 | $52,888 | 37.2% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 54 | 110 | $89,947 | $27,895 | 31.0% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 71 | 1,350 | $37,800 | $14,105 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $19,080 | $6,967 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 91 | $15,561 | $5,651 | 36.3% |
| 77011 | Ct guidance for needle or tube localization | Office | 2023 | 37 | 38 | $20,900 | $5,535 | 26.5% |
| 61782 | Computer-assisted procedure outside membrane covering brain | Facility | 2023 | 21 | 21 | $6,993 | $2,757 | 39.4% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 12 | 480 | $7,200 | $2,716 | 37.7% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 37 | 376 | $6,392 | $2,436 | 38.1% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 26 | 26 | $9,100 | $2,068 | 22.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 12 | 468 | $3,276 | $1,331 | 40.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 26 | 163 | $3,260 | $1,255 | 38.5% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 11 | 11 | $2,640 | $1,042 | 39.5% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 23 | 24 | $1,728 | $669.88 | 38.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 19 | 23 | $2,047 | $583.23 | 28.5% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 18 | 22 | $1,848 | $507.94 | 27.5% |
| 92567 | Test to assess middle ear function | Office | 2023 | 23 | 24 | $744.00 | $293.27 | 39.4% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 234 | 566 | $186,220 | $75,636 | 40.6% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 58 | 127 | $90,766 | $29,799 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 317 | $74,247 | $29,755 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 384 | $46,029 | $22,543 | 49.0% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 60 | 1,170 | $28,060 | $11,923 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $17,229 | $6,731 | 39.1% |
| 77011 | Ct guidance for needle or tube localization | Office | 2022 | 29 | 29 | $21,019 | $4,388 | 20.9% |
About Dr. Thomas Higgins, MD
Dr. Thomas Higgins, MD is a Otolaryngology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1750543237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Higgins, MD has received a total of $419,217 in payments from pharmaceutical and medical device companies, with $114,714 received in 2024. These payments were reported across 655 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($226,614).
As a Medicare-enrolled provider, Higgins has provided services to 3,972 Medicare beneficiaries, totaling 15,045 services with total Medicare billing of $774,739. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Louisville, KY
- Active Since 06/26/2008
- Last Updated 02/03/2022
- Taxonomy Code 207Y00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750543237
Products in Payments
- DUPIXENT (Biological) $211,653
- Xhance (Drug) $73,131
- NEUROMARK Device (Device) $56,412
- DUPIXENT (Drug) $13,983
- ACCLARENT Balloon Inflation Device (Device) $11,810
- Xolair (Biological) $6,444
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $6,113
- PROPEL (Device) $3,299
- LATERA (Device) $2,975
- NUCALA (Biological) $2,073
- SINUVA (Drug) $1,343
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $1,057
- VIVAER STYLUS (Device) $799.78
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM (Device) $580.86
- XPRESS ENT DILATION SYSTEM (Device) $345.70
- SCOPIS ENT (Device) $343.39
- No Product (Device) $300.00
- COLORADO (Device) $290.46
- FIAGON NAVIGATION UNIT (Device) $286.39
- FUSION (Device) $263.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Louisville
Dr. Sean Maguire, M.d, M.D
Otolaryngology — Payments: $64,573
Otolaryngology $64,573
Steven Shotts, Md, MD
Otolaryngology — Payments: $14,217
Otolaryngology $14,217
Amy Ingram, Md, MD
Otolaryngology — Payments: $7,136
Otolaryngology $7,136
Aaron Smith, Md, MD
Otolaryngology — Payments: $6,458
Otolaryngology $6,458
Matthew Yantis, M.d, M.D
Otolaryngology — Payments: $6,199
Otolaryngology $6,199
Kevin Potts, M.d, M.D
Otolaryngology — Payments: $6,053
Otolaryngology $6,053